Medpace Holdings Capital Expenditures (CapEx) Growth & History (MEDP)
Medpace Holdings's capital expenditures (capex) was $31.4M for fiscal 2025.
View full Medpace Holdings company overviewMedpace Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $31.4M | −$5.2M | −14.21% |
| 2024 | 2024-12-31 | $36.5M | −$100,000 | −0.27% |
| 2023 | 2023-12-31 | $36.6M | −$231,000 | −0.63% |
| 2022 | 2022-12-31 | $36.9M | $8.6M | +30.45% |
| 2021 | 2021-12-31 | $28.3M | −$3.1M | −9.79% |
| 2020 | 2020-12-31 | $31.3M | $13.4M | +74.97% |
| 2019 | 2019-12-31 | $17.9M | $1.9M | +11.78% |
| 2018 | 2018-12-31 | $16.0M | $4.3M | +36.68% |
| 2017 | 2017-12-31 | $11.7M | −$1.8M | −13.39% |
| 2016 | 2016-12-31 | $13.5M | $7.1M | +109.39% |
| 2015 | 2015-12-31 | $6.5M | — | — |
Medpace Holdings quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $23.9M | $17.8M | +291.15% |
| Q1 2026 | 2026-03-31 | $6.8M | −$3.2M | −31.82% |
| Q4 2025 | 2025-12-31 | $4.5M | −$3.1M | −40.65% |
| Q3 2025 | 2025-09-30 | $10.7M | $176,000 | +1.67% |
| Q2 2025 | 2025-06-30 | $6.1M | −$6.8M | −52.51% |
| Q1 2025 | 2025-03-31 | $10.0M | $4.5M | +81.81% |
| Q4 2024 | 2024-12-31 | $7.6M | −$2.3M | −23.46% |
| Q3 2024 | 2024-09-30 | $10.5M | $1.8M | +21.07% |
| Q2 2024 | 2024-06-30 | $12.9M | $4.4M | +52.39% |
| Q1 2024 | 2024-03-31 | $5.5M | −$4.0M | −42.22% |
| Q4 2023 | 2023-12-31 | $10.0M | $743,000 | +8.04% |
| Q3 2023 | 2023-09-30 | $8.7M | $1.5M | +21.23% |
| Q2 2023 | 2023-06-30 | $8.4M | −$2.8M | −24.59% |
| Q1 2023 | 2023-03-31 | $9.5M | $256,000 | +2.77% |
| Q4 2022 | 2022-12-31 | $9.2M | $127,000 | +1.39% |
| Q3 2022 | 2022-09-30 | $7.2M | $539,000 | +8.12% |
| Q2 2022 | 2022-06-30 | $11.2M | $5.2M | +86.42% |
| Q1 2022 | 2022-03-31 | $9.3M | $2.8M | +42.26% |
| Q4 2021 | 2021-12-31 | $9.1M | $1.3M | +17.08% |
| Q3 2021 | 2021-09-30 | $6.6M | −$2.0M | −23.41% |
| Q2 2021 | 2021-06-30 | $6.0M | −$3.3M | −35.56% |
| Q1 2021 | 2021-03-31 | $6.5M | $946,000 | +17.01% |
| Q4 2020 | 2020-12-31 | $7.8M | $2.0M | +35.17% |
| Q3 2020 | 2020-09-30 | $8.7M | $2.5M | +40.68% |
| Q2 2020 | 2020-06-30 | $9.3M | $5.9M | +168.70% |
| Q1 2020 | 2020-03-31 | $5.6M | $3.0M | +120.67% |
| Q4 2019 | 2019-12-31 | $5.8M | $2.3M | +67.00% |
| Q3 2019 | 2019-09-30 | $6.2M | $3.4M | +121.50% |
| Q2 2019 | 2019-06-30 | $3.5M | −$2.4M | −40.60% |
| Q1 2019 | 2019-03-31 | $2.5M | −$1.4M | −36.22% |
| Q4 2018 | 2018-12-31 | $3.4M | $54,000 | +1.59% |
| Q3 2018 | 2018-09-30 | $2.8M | $472,000 | +20.43% |
| Q2 2018 | 2018-06-30 | $5.8M | $4.2M | +255.14% |
| Q1 2018 | 2018-03-31 | $4.0M | −$423,000 | −9.67% |
| Q4 2017 | 2017-12-31 | $3.4M | −$2.3M | −40.38% |
| Q3 2017 | 2017-09-30 | $2.3M | $160,000 | +7.44% |
| Q2 2017 | 2017-06-30 | $1.6M | −$592,000 | −26.46% |
| Q1 2017 | 2017-03-31 | $4.4M | $918,000 | +26.56% |
| Q4 2016 | 2016-12-31 | $5.7M | — | — |
| Q3 2016 | 2016-09-30 | $2.1M | — | — |
| Q2 2016 | 2016-06-30 | $2.2M | — | — |
| Q1 2016 | 2016-03-31 | $3.5M | — | — |
Medpace Holdings capital expenditures (capex) trends
Over the last five fiscal years, Medpace Holdings's capital expenditures (capex) increased from $31.3M to $31.4M, a change of $16,000. The latest reported quarter, Q2 2026, shows $23.9M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medpace Holdings source filings ↗